JONATHAN SLONIN - 01 Aug 2025 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Chief Medical Officer
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 01 Aug 2025
Net transactions value: -$6,952
Form type: 4
Filing time: 04 Aug 2025, 16:31:02 UTC
Previous filing: 05 Jun 2025
Next filing: 19 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SLONIN JONATHAN	Chief Medical Officer	C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE	/s/ Kristen Williams, Attorney-in-Fact	04 Aug 2025	0001875723

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Tax liability	$6,952	-315	-0.17%	$22.07	182,327	01 Aug 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
F2	Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025.